Our Products
Our product range contains a wide range of Trastuzumab 440 Mg Injection
Trastuzumab is a recombinant humanized monoclonal antibody that selectively binds to the HER2 (human epidermal growth factor receptor 2) protein, inhibiting tumor growth in HER2-positive cancers. It is indicated for the treatment of HER2-positive breast cancer and HER2-positive metastatic gastric or gastroesophageal junction adenocarcinoma, either alone or in combination with chemotherapy. It works by blocking HER2 signaling and triggering immune-mediated cancer cell destruction